Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Losartan potassium 50 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
pantoprazol (som pantoprazolnatriumseskvihydrat) 40 milligram, enterotablett |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
venlafaxin 37,5 mg, tablett |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Fenbufen 450 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Thioridazine hydrochloride 200 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Morphine sulfate 50 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Tetracycline 500 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cefradine 1 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cefradine 1 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefradine 1 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amphotericin B 50 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Amphotericin B 50 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Dantrolene sodium 20 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Dantrolene sodium 20 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 20 microgram powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
ceftazidim (som ceftazidimpentahydrat) 3 gram/injektionsflaska, pulver till injektionsvätska |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
ceftazidim (som ceftazidimpentahydrat) 3 gram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 40 microgram powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 40 microgram powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
doripenem (som doripenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
doripenem (som doripenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 5 microgram powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alprostadil 5 microgram powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Alteplase 10 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Alteplase 10 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aztreonam 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aztreonam 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Aztreonam 1 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Aztreonam 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Aztreonam 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amobarbital sodium 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Amobarbital sodium 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Basiliximab 10 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Basiliximab 10 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Basiliximab 20 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Basiliximab 20 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |